Adam L. Muzikant
Nessuna posizione attualmente
Provenienza dei contatti di primo grado di Adam L. Muzikant
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Subsidiary | Pharmaceuticals: Major | 27 | |
EPIX Pharmaceuticals, Inc.
 EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA.
14
| Extinct | Medical Specialties | 14 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Adam L. Muzikant tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Medical Specialties | Corporate Officer/Principal General Counsel General Counsel Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Stanford University | College/University | Masters Business Admin Masters Business Admin Graduate Degree Doctorate Degree Graduate Degree Undergraduate Degree | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Graduate Degree | |
| INVIVYD, INC. | Biotechnology | Director of Finance/CFO Investor Relations Contact Human Resources Officer | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| BIOGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| Harvard Medical School | College/University | Doctorate Degree Doctorate Degree | |
| AKEBIA THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| Babson College | College/University | Undergraduate Degree Masters Business Admin | |
| AMAG PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director of Finance/CFO | |
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology ViaCyte, Inc. develops a stem cell-derived islet replacement therapy for the treatment of diabetes. Its development portfolio includes VC-01 product candidate, a cell replacement therapy for the treatment of type 1 diabetes. The company was founded in 1999 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| Yale University | College/University | Undergraduate Degree Undergraduate Degree | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
| UCLA Anderson School of Management | College/University | Masters Business Admin Masters Business Admin | |
| University of Michigan | College/University | Undergraduate Degree Doctorate Degree | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Harvard T.H. Chan School of Public Health | College/University | Graduate Degree Graduate Degree | |
| KINETA, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Yumanity, Inc.
 Yumanity, Inc. Pharmaceuticals: MajorHealth Technology Yumanity, Inc. engages in transforming drug discovery for neurodegenerative diseases services. It provides integrated discovery platforms, phenotypic screening (uHTS) platforms, in which different protein misfolding pathologies are modeled in yeast to help discover compounds to correct these pathologies; a human neuronal platform. The company was founded by Anthony N. Coles, Jr. and Susan L. Lindquist in December 2014 and is headquartered in Boston, MA. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| THE MEDICINES COMPANY | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
Nido Biosciences, Inc.
 Nido Biosciences, Inc. BiotechnologyHealth Technology Nido Biosciences, Inc. focuses on developing small molecule therapeutics for the treatment of neurodegenerative diseases. The company is headquartered in Boston, MA. | Biotechnology | Chairman Chief Operating Officer | |
| The Trustees of Columbia University in The City of New York | College/University | Graduate Degree Doctorate Degree | |
| Perelman School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
Lilly Research Laboratories
 Lilly Research Laboratories Miscellaneous Commercial ServicesCommercial Services Part of Eli Lilly & Co., Lilly Research Laboratories is a company that engages in research and develops medicines. The company is based in Indianapolis, IN. | Miscellaneous Commercial Services | Corporate Officer/Principal Chief Operating Officer | |
| Boston University | College/University | Graduate Degree Undergraduate Degree | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| CUE BIOPHARMA, INC. | Biotechnology | Director/Board Member Director of Finance/CFO | |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Onyx Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in developing innovative therapies that target the molecular mechanisms that cause cancer. The company was founded by Frank McCormick in February 1992 and is headquartered in Thousand Oaks, CA. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Genelabs Technologies, Inc.
 Genelabs Technologies, Inc. Pharmaceuticals: MajorHealth Technology Genelabs Technologies, Inc. discovery and development of pharmaceutical products to improve human health. The company was founded by Brian D. Frenzel and Frank C. Kung in 1983 and is headquartered in Redwood, CA. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| University of Wisconsin | College/University | Doctorate Degree Undergraduate Degree | |
| STANDARD BIOTOOLS INC. | Medical Specialties | Chairman Corporate Officer/Principal | |
| AKCEA THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| Sanofi Corp. | Corporate Officer/Principal Corporate Officer/Principal | ||
| Bentley University | College/University | Undergraduate Degree Masters Business Admin | |
| VERTEX PHARMACEUTICALS INCORPORATED | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| INFINITY PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Metamark Genetics, Inc.
 Metamark Genetics, Inc. Medical/Nursing ServicesHealth Services Metamark Genetics, Inc. provides molecular diagnostics services. It develops prognostic and predictive diagnostic tests that will enable personalized treatment planning for cancer patients. It transforms cancer diagnosis and treatment by developing pioneering diagnostic products based on its prognosis determinants platform. The company was founded by Kenneth E. Weg, Raju S. Kucherlapati, David Rimm, Lynda Chin and Ronald A. DePinho in November 2007 and is headquartered in Waltham, MA. | Medical/Nursing Services | Director/Board Member | |
| ANAPTYSBIO, INC. | Biotechnology | Director/Board Member | |
| VERASTEM, INC. | Biotechnology | Chairman | |
| BLUEPRINT MEDICINES CORPORATION | Biotechnology | Director of Finance/CFO |
Statistiche
Distribuzione geografica
| Stati Uniti | 49 |
| Israele | 3 |
Settori
| Health Technology | 31 |
| Consumer Services | 18 |
| Commercial Services | 2 |
| Health Services | 2 |
Posizioni
| Director/Board Member | 221 |
| Corporate Officer/Principal | 106 |
| Independent Dir/Board Member | 74 |
| Chairman | 44 |
| Undergraduate Degree | 39 |
Contatti più connessi
| Insiders | |
|---|---|
| Heath Lukatch | 43 |
| Samuel D. Colella | 31 |
| Robert Perez | 31 |
| Fredrick Frank | 30 |
| Michael Kauffman | 24 |
| Ian Smith | 24 |
| C. Merrifield | 24 |
| Patrick J. Fortune | 24 |
| Kimberlee Drapkin | 23 |
| Fred Driscoll | 21 |
| Christopher F. O. Gabrieli | 21 |
| Alan Milinazzo | 20 |
| David Arkowitz | 20 |
| Scott Canute | 17 |
| Peter Wirth | 15 |
- Borsa valori
- Insiders
- Adam L. Muzikant
- Connessioni Società